李志衍;赵婷婷;曹玉颖;张希墨;邱基程;郭燕莹;李淑媛;张璐;龚晓会;吴琴尧;曹兴元;

• 1:北京市畜牧总站
• 2:中国农业大学动物医学院
• 3:国家兽药安全评价中心

摘要(Abstract)：

为了研究阿莫西林-克拉维酸钾可溶性粉在猪体内的药代动力学特征,笔者以12.5 mg/kg·bw剂量单次给猪灌服阿莫西林-克拉维酸钾可溶性粉,于给药前和给药后特定时间点采集血浆样品,采用UPLC-MS/MS法测定血浆药物浓度,并使用WinNonlin R 8.1软件进行非房室模型分析。内服给药后,阿莫西林和克拉维酸的T1/2无显著差异(分别为1.14±0.24 h和1.32±0.29 h),二者的Cmax分别为2.58±0.67μg/mL和1.91±0.28μg/mL,Tmax分别为1.67±0.34 h和1.46±0.10 h,AUClast分别为7.33±1.80 mg·h/L和4.98±0.67 mg·h/L。阿莫西林和克拉维酸的平均内服生物利用度分别为23.0%和26.4%。试验结果说明,本研究建立的检测方法灵敏度高、干扰少,适用于猪血浆中阿莫西林-克拉维酸钾的检测;药代动力学研究表明2种药代谢快,在猪体内的停留时间较短。

关键词(KeyWords)： 阿莫西林;克拉维酸;猪;UPLC-MS/MS;药代动力学

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 李志衍;赵婷婷;曹玉颖;张希墨;邱基程;郭燕莹;李淑媛;张璐;龚晓会;吴琴尧;曹兴元;

Email:

DOI:

参考文献(References)：

• [1]蔡文辉，张文莉，付英梅，等.β-内酰胺酶抑制剂研究进展[J].中国抗生素杂志，2013,38(11):805-809.
• [2] Kaye CM,Allen A,Perry S,et al.The clinical pharmacokinetics of a new pharmacokinetically enhanced formula tion of amoxicillin/clavulanate[J].ClinTher,2001,23(4):578-584.
• [3] White A R,Kaye C,Poupard J,et al.Augmentin R(amox icillin/clavulanate)in the treatment of community-acquired respiratory tract infection:a review of the continuing development of an innovative antimicrobial agent[J].Journal of Antimicrobial Chemotherapy,2004,53(90001):3-20.
• [4]侯芳，张朴，刘燕，等.阿莫西林/克拉维酸钾片在健康人体的药代动力学与药效学[J].中国临床药理学杂志，2006,22(1):40-43.
• [5] Escudero E,Vicente M S,Carceles C M.Pharmacokinetics of amoxicillin/clavulanic acid combination after intravenous and intramuscular administration to pigeons[J].Research in Veterinary Science,1998,65(1):77-81.
• [6] Vree T B,Dammers E,Van Duuren E.Variable Absorption of Clavulanic Acid After an Oral Dose of 25 mg/kg of Clavuba-ctinR and SynuloxRin Healthy Dogs[J].Journal of veterinary pharmacology and therapeutics,2003,26(3):165-171.
• [7]闫超群.犬用阿莫西林克拉维酸钾片生物等效性研究[D].广东：华南农业大学，2016.
• [8]郭敏.阿莫西林/克拉维酸钾片在猫体内的药动学及安全性评价研究[D].江苏：南京农业大学，2011.
• [9] Carceles C M,Escudero E,Vicente M S,et al.Pharmacokinetics of amoxicillin/clavulanic acid combination after intravenous and oral administration in goats[J].Veterinary Quarterly,1995,17(4):134-138.
• [10] Carceles C M,Escudero E,Baggot J D.Comparative pharmacokinetics of amoxicillin/clavulanic acid combination after intravenous administration to sheep and goats[J].Journal of Veterinary Pharmacology and Therapeutics,1995,18(2):132-136.
• [11] Jerzsele A,Nagy G,Lehel J,et al.Oral bioavailability and pharmacokinetic profile of the amoxicillin-clavulanic acid combination after intravenous and oral gavage administration in broiler chickens[J].Journal of Veterinary Pharmacology and Therapeutics,2009,32(5):506-509.
• [12] Reyns T,De B S,Baert K,et al.Disposition and oral bioava-ilability of amoxicillin and clavulanic acid in pigs[J].Journal of Veterinary Pharmacology&Therapeutics,2007,30(6):550-555.
• [13]汤树生，肖希龙.阿莫西林-克拉维酸注射剂及其在猪体内的药物动力学研究[J].畜牧兽医学报，2004,35(6):720-726.
• [14]农业部兽药评审中心.兽药研究技术指导原则汇编[M].北京：化学工业出版社，2012:60-65.
• [15] Reyns T,Baere S D,Croubels S.Determination of clavulanic acid in calf plasma by liquid chromatography tandem mass spectrometry[J].Journal of Mass Spectrometry,2010,41(11):1414-1420.
• [16] Agers覬H,Friis C.Bioavailability of amoxycillin in pigs[J].Journal of Veterinary Pharmacology and Therapeutics,1998,21(1):41-46.